Effects of replacement of ascorbic acid in patients undergoing hemodialysis: A Clinical trial
Context: Anemia is common in patients with chronic kidney disease undergoing hemodialysis treatment, and oxidative stress and persistent inflammatory state are important for its genesis. Ascorbic acid, a known antioxidant, can serve as an adjunct to your management. Objective: to evaluate the effect of intravenous ascorbic acid’s replacement in chronic renal patients undergoing hemodialysis.